Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-12-037472
Filing Date
2012-05-15
Accepted
2012-05-15 16:05:11
Documents
11
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a12-9778_110q.htm 10-Q 1521973
2 EX-31.1 a12-9778_1ex31d1.htm EX-31.1 9987
3 EX-31.2 a12-9778_1ex31d2.htm EX-31.2 9951
4 EX-32.1 a12-9778_1ex32d1.htm EX-32.1 4670
5 EX-32.2 a12-9778_1ex32d2.htm EX-32.2 4665
  Complete submission text file 0001104659-12-037472.txt   4626131

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT trov-20120331.xml EX-101.INS 379584
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT trov-20120331.xsd EX-101.SCH 39317
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT trov-20120331_cal.xml EX-101.CAL 97458
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT trov-20120331_lab.xml EX-101.LAB 508195
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT trov-20120331_pre.xml EX-101.PRE 199506
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT trov-20120331_def.xml EX-101.DEF 142447
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-217-5420
TrovaGene Inc. (Filer) CIK: 0001213037 (see all company filings)

EIN.: 043721895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54556 | Film No.: 12844574
SIC: 2836 Biological Products, (No Diagnostic Substances)